TGM2 is highly expressed and active in endometriosis where it mediates pro-fibrotic and pro-inflammatory effects by Estrada, F, Obendorf, M, Mesch, S, Fischer, O, Bafligil, C, Guo, M, Becker, C, Zondervan, K, Shang, C, Kennedy, S, Gordon, S, Zollner, T, Oppermann, U

Quantitative characterization by mass cytometry reveals a complex immune environment and activation pattern in the peritoneal fluid of endometriosis patients by Guo, M, Bafligil, C, Tapmeier, T, Hubbard, C, Dale, M, Manek, S, Shang, C, Obendorf, M, Sacher, F, Fischer, O, Hess-Stumpp, H, Zollner, T, Kennedy, S, Becker, C, Zondervan, K, Soderstrom, K, Oppermann, U

Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis by Tapmeier, TT, Rahmioglu, N, Lin, J, De Leo, B, Obendorf, M, Raveendran, M, Fischer, OM, Bafligil, C, Guo, M, Harris, RA, Hess-Stumpp, H, Laux-Biehlmann, A, Lowy, E, Lunter, G, Malzahn, J, Martin, NG, Martinez-Estrada, F, Manek, S, Mesch, S, Montgomery, GW, Morris, AP, Nagel, J, Simmons, HA, Brocklebank, D, Shang, C, Treloar, S, Wells, G, Becker, C, Oppermann, U, Zollner, TM, Kennedy, SH, Kemnitz, J, Rogers, J, Zondervan, KT